(Q35591109)

9 August 2017

1 reference

title

ErbB receptors: possible therapeutic targets in prostate cancer? (English)

1 reference

9 August 2017

1 reference

H L Ratan

1

1 reference

9 August 2017

A Gescher

series ordinal

2

1 reference

9 August 2017

W P Steward

series ordinal

3

1 reference

9 August 2017

J K Mellon

series ordinal

4

1 reference

9 August 2017

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

92

1 reference

9 August 2017

9

1 reference

9 August 2017

890-895

1 reference

Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer

9 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Growth factors and their receptors: new targets for prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Androgens and transforming growth factor beta modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04503.X

10.1111/J.1464-410X.2003.04503.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference